Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure
Reserve your place

Latest News

See what's going on at eyeforpharma Medical Affairs.

Next-generation Medical Affairs – white paper How many people 20 years ago do you think would have believed you if you told them Medical Affairs is the future of pharma? Such has been the growth of Medical’s stature oveMedicar recent years, the function has grown from a supplementary to playing a vital role in pharma’s strategic plans, ambition and vision. As we discovered in our latest white paper, to stay ahead of this ever-increasing list of both external and internal demands and responsibilities, a new Medical operating model is a must – with each company’s approach their own.

One giant leap for Medical Affairs Kirk Shepard, President of the Medical Affairs Professional Society, and former Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Pharma, believes that the increasingly customer-facing role of Medical is one of the biggest challenges that this department faces.
Click here to read the full article.

Boosting Medical’s Role in Early Development Paul Rowe, VP and Global Medical Affairs Head, Respiratory at Sanofi Genzyme and Peter Rutherford, VP at QuintilesIMS, discuss how medical can truly drive value via collaboration with R&D.
Click here to read the full article.

Medical Affairs Disrupted Shontelle Dodson, Vice President, Medical Excellence/Medical Affairs Global & Karen Lowney, Executive Director, Global Compliance, Privacy & Transparency from Astellas Pharma, and Roslyn Schneider, Global Patient Affairs Lead at Pfizer, spoke to us about how medical affairs is now the patient-centric driving force in their companies.
Click here to read the full article.

RWE and its impact on Medical Affairs Pam Bacon, Executive Director of Medical Affairs at Celgene discusses how RWE will improve medical communications, patient adherence and internal and external collaborations.
Click here to hear her presentation.

New magazine: Real world revolution Many claim we are in the middle of an ‘evidence revolution’ which has the potential to influence the entire drug lifecycle, from discovery to late-stage commercial. Tasking MSLs with gathering, analyzing and distributing Real World Evidence is key to your company’s ongoing success. In eyeforpharma’s latest thought piece – Trends in Real World Evidence – we explore how leading companies unleash the value of real world insights, and the biggest challenges and opportunities they face.
Click here to download your free copy today.

Medical Affairs Leadership webinar In the first webinar of its kind, we invited leading experts to debate:
• How we can redefine the role of medical affairs leadership
• Which strategic shifts need to be made to successfully gather and analyse data
• How MSLs can work in partnership with sales and marketing teams
• The future of medical: what is our role?.
Click here to listen to the recording.

Architects of Value Chief Medical Officer at Sanofi, Dr Ameet Nathwani, discusses the vital role Medical Affairs is playing in using data to demonstrate value.
Click here to read the full article.

New magazine: The Changing Face of Medical Affairs Ameet Nathwani (CMO, Sanofi) is among the hundreds of pharma execs who recognise the growing importance of Medical Affairs. He envisages a transformation to become a fully-fledged strategic partner alongside commercial and R&D. With so much change taking place, eyeforpharma recently quizzed senior medical affairs experts from Sanofi, Takeda, GSK, Celgene and AstraZeneca to put together a thought provoking mini-magazine which addresses key issues -
Click here to download your free copy today.


Join the Medical Affairs community

Stay updated, receive the latest content and download your brochure.

If you are interested in getting involved in the eyeforpharma Medical Affairs USA summit, please contact me on the details below.

James Mackintosh

James Mackintosh

Global project Director
eyeforpharma

Phone (US): +1800 814 3459 7163

Phone (Global): +44 (0) 207 375 7163

Email: jmackintosh@eyeforpharma.com